Publications by authors named "Monna E Myllykangas"

Thromboembolism prophylaxis after biologic aortic valve replacement (BAVR) is recommended for 3 months postoperatively. We examined the continuation of oral anticoagulation (OAC) treatment and its effect on the long-term prognosis after BAVR. We used nation-wide register data from 4,079 individuals who underwent BAVR.

View Article and Find Full Text PDF

Objectives: Women are considered to have poorer prognoses after cardiac surgery, although evidence is scarce. The authors studied sex differences and long-term outcomes after surgical aortic valve replacement (SAVR).

Design: Nationwide retrospective cohort study.

View Article and Find Full Text PDF

. To investigate nationwide changes in procedure rates, patient selection, and prognosis after all surgical aortic valve replacements. .

View Article and Find Full Text PDF

Background: Biologic prostheses are preferred for surgical aortic valve replacement (SAVR) in patients more than 70 years of age in clinical practice. This study investigated differences in long-term outcomes between SAVR-treated patients more than 70 years of age who received mechanical or biologic prosthetic valves.

Methods: All patients (excluding those with endocarditis) who were more than 70 years of age and who underwent isolated first-time SAVR (with or without coronary artery bypass grafting) in Finland between 2004 and 2014 were retrospectively studied (n = 4227).

View Article and Find Full Text PDF

Objectives: Contemporary, nationwide data on trends in mitral valve surgery are scarce. Our aim was to investigate changes in procedure rates, patient selection, and post-procedural prognosis of open-heart mitral valve surgery in Finland.

Design: We combined data from three nationwide administrative registers with compulsory reporting.

View Article and Find Full Text PDF